Fifteen days following cancer cell grafting the presence of tumors was confirmed by bioluminescence imaging (BLI), and mice were treated with CSPG4 CAR T cells or CD19 CAR T cells, administered as a single dose by tail vein injection (Fig. 3A). This evidence concerns the gene CD19 and cancer.